| Company Name | Boehringer Ingelheim Taiwan |
|---|---|
| Protocol Number | 1199-0303 |
| Title of Study | Non-Interventional study (NIS) Collecting Experiences For IPF in Taiwan |
| Primary Objective | The primary objective is to characterize the IPF population in Taiwan with regard to their clinical course under clinical practice conditions in Taiwan. The secondary objectives are to understand the clinical characteristics and quality of life of IPF population in Taiwan. |
| Number of Sites | 10 |
| Period of Study | From：2017May31 to：2019 Dec 31 |
| Number of Patients | 100人 |
| IRB Approval Date | 三軍總醫院 3-Jul-2017 |
| Publication Plan / Date | Q4 2020 |
